FREE NEJM E-TOC    HOME   |   SUBSCRIBE   |   CURRENT ISSUE   |   PAST ISSUES   |   COLLECTIONS   |   Search Term  Advanced Search

Sign in | Get NEJM's E-Mail Table of Contents — Free | Subscribe

Previous Volume 351:601-603 August 5, 2004 Number 6 Next

	Since this article has no abstract, we have provided an extract of the first 100 words of the full text and any section headings.

	Full Text PDF PDA Full Text Purchase this article Add to Personal Archive Add to Citation Manager Notify a Friend E-mail When Cited E-mail When Letters Appear Related Article by Holleman, A. PubMed Citation

Since 1970, the rate of cure of acute lymphoblastic leukemia (ALL) in children has increased dramatically, from less than 30 percent to approximately 80 percent. This remarkable improvement has resulted from the marriage of laboratory and clinical science. The identification of effective agents in randomized cooperative-group studies, the application of treatment to the central nervous system before the onset of symptoms, the intensification of treatment, and the use of "risk-adapted therapy" (therapy tailored to the predicted risk of relapse) have led to today's impressive cure rates.

Despite these successes, however, much work remains. Many of the children with ALL who . . . [Full Text of this Article]

Source Information

From the University of Texas Southwestern Medical Center, Dallas (N.J.W.); New York University School of Medicine and Mount Sinai School of Medicine, New York (W.L.C.); and the University of Florida College of Medicine, Gainesville (S.P.H.).

This article has been cited by other articles:

• Linger, R. M. A., DeRyckere, D., Brandao, L., Sawczyn, K. K., Jacobsen, K. M., Liang, X., Keating, A. K., Graham, D. K. (2009). Mer receptor tyrosine kinase is a novel therapeutic target in pediatric B-cell acute lymphoblastic leukemia. Blood 114: 2678-2687 [Abstract] [Full Text]  
• Winter, S. S., Jiang, Z., Khawaja, H. M., Griffin, T., Devidas, M., Asselin, B. L., Larson, R. S. (2007). Identification of genomic classifiers that distinguish induction failure in T-lineage acute lymphoblastic leukemia: a report from the Children's Oncology Group. Blood 110: 1429-1438 [Abstract] [Full Text]  
• Schultz, K. R., Pullen, D. J., Sather, H. N., Shuster, J. J., Devidas, M., Borowitz, M. J., Carroll, A. J., Heerema, N. A., Rubnitz, J. E., Loh, M. L., Raetz, E. A., Winick, N. J., Hunger, S. P., Carroll, W. L., Gaynon, P. S., Camitta, B. M. (2007). Risk- and response-based classification of childhood B-precursor acute lymphoblastic leukemia: a combined analysis of prognostic markers from the Pediatric Oncology Group (POG) and Children's Cancer Group (CCG). Blood 109: 926-935 [Abstract] [Full Text]  
• Taylor, A. L., Wright, J. T. Jr, Cooper, R. S., Psaty, B. M., Taylor, A. L., Wright, J. T. Jr, Cooper, R. S., Psaty, B. M. (2005). Importance of Race/Ethnicity in Clinical Trials: Lessons From the African-American Heart Failure Trial (A-HeFT), the African-American Study of Kidney Disease and Hypertension (AASK), and the Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial (ALLHAT). Circulation 112: 3654-3666 [Full Text]  
• Zaza, G., Cheok, M., Yang, W., Panetta, J. C., Pui, C.-H., Relling, M. V., Evans, W. E. (2005). Gene expression and thioguanine nucleotide disposition in acute lymphoblastic leukemia after in vivo mercaptopurine treatment. Blood 106: 1778-1785 [Abstract] [Full Text]  
• Avellino, R., Romano, S., Parasole, R., Bisogni, R., Lamberti, A., Poggi, V., Venuta, S., Romano, M. F. (2005). Rapamycin stimulates apoptosis of childhood acute lymphoblastic leukemia cells. Blood 106: 1400-1406 [Abstract] [Full Text]  
• Nagourney, R. (2005). Chemosensitivity and Resistance Assays: A Systematic Review?. JCO 23: 3640-3641 [Full Text]  
• Schrag, D., Samson, D. J., Seidenfeld, J., Aronson, N., Garewal, H., Burstein, H. J., Von Hoff, D. D., Somerfield, M. R. (2005). In Reply:. JCO 23: 3646-3648 [Full Text]